company background image
M3V logo

MeVis Medical Solutions XTRA:M3V Stock Report

Last Price

€24.40

Market Cap

€44.4m

7D

0.8%

1Y

-6.9%

Updated

30 Oct, 2024

Data

Company Financials

MeVis Medical Solutions AG

XTRA:M3V Stock Report

Market Cap: €44.4m

M3V Stock Overview

Develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe.

M3V fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends3/6

MeVis Medical Solutions AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MeVis Medical Solutions
Historical stock prices
Current Share Price€24.40
52 Week High€27.40
52 Week Low€22.80
Beta0.026
11 Month Change6.09%
3 Month Change-4.69%
1 Year Change-6.87%
33 Year Change-24.22%
5 Year Change-18.12%
Change since IPO-52.04%

Recent News & Updates

MeVis Medical Solutions (ETR:M3V) Is Very Good At Capital Allocation

Nov 30
MeVis Medical Solutions (ETR:M3V) Is Very Good At Capital Allocation

Recent updates

MeVis Medical Solutions (ETR:M3V) Is Very Good At Capital Allocation

Nov 30
MeVis Medical Solutions (ETR:M3V) Is Very Good At Capital Allocation

Most Shareholders Will Probably Find That The CEO Compensation For MeVis Medical Solutions AG (ETR:M3V) Is Reasonable

Mar 16
Most Shareholders Will Probably Find That The CEO Compensation For MeVis Medical Solutions AG (ETR:M3V) Is Reasonable

MeVis Medical Solutions (ETR:M3V) Has More To Do To Multiply In Value Going Forward

Feb 14
MeVis Medical Solutions (ETR:M3V) Has More To Do To Multiply In Value Going Forward

Should You Use MeVis Medical Solutions' (ETR:M3V) Statutory Earnings To Analyse It?

Feb 22
Should You Use MeVis Medical Solutions' (ETR:M3V) Statutory Earnings To Analyse It?

MeVis Medical Solutions AG's (ETR:M3V) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Feb 01
MeVis Medical Solutions AG's (ETR:M3V) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Shareholder Returns

M3VDE Healthcare ServicesDE Market
7D0.8%-2.2%-1.0%
1Y-6.9%-38.9%16.1%

Return vs Industry: M3V exceeded the German Healthcare Services industry which returned -36.9% over the past year.

Return vs Market: M3V underperformed the German Market which returned 18.1% over the past year.

Price Volatility

Is M3V's price volatile compared to industry and market?
M3V volatility
M3V Average Weekly Movement2.1%
Healthcare Services Industry Average Movement5.3%
Market Average Movement5.0%
10% most volatile stocks in DE Market10.9%
10% least volatile stocks in DE Market2.4%

Stable Share Price: M3V has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: M3V's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997116Marcus Kirchhoffwww.mevis.de

MeVis Medical Solutions AG develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers.

MeVis Medical Solutions AG Fundamentals Summary

How do MeVis Medical Solutions's earnings and revenue compare to its market cap?
M3V fundamental statistics
Market cap€44.41m
Earnings (TTM)€5.75m
Revenue (TTM)€17.64m

7.7x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
M3V income statement (TTM)
Revenue€17.64m
Cost of Revenue€10.72m
Gross Profit€6.93m
Other Expenses€1.18m
Earnings€5.75m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jan 30, 2025

Earnings per share (EPS)3.16
Gross Margin39.27%
Net Profit Margin32.60%
Debt/Equity Ratio0%

How did M3V perform over the long term?

See historical performance and comparison

Dividends

3.9%

Current Dividend Yield

30%

Payout Ratio